Scott Wolchko | President and CEO |
Ed Dulac | CFO |
Yigal Nochomovitz | Citi |
Michael Schmidt | Guggenheim |
Alethia Young | Cantor Fitzgerald |
Michael Yee | Jefferies |
Daina Graybosch | SVB Leerink |
Ben Burnett | Stifel |
Peter Lawson | Barclays |
Matt Biegler | Oppenheimer |
Mara Goldstein | Mizuho |
Srikripa Devarakonda | Truist Securities |
Nick Abbott | Wells Fargo |
Welcome to the Fate Therapeutics Second Quarter 2021 Financial Results Conference Call. At this time all participants are in a listen-only mode. This call is being webcast live on the Investors section of Fate's website at fatetherapeutics.com.
As a reminder, today's call is being recorded. I would now like to introduce Scott Wolchko, President and CEO of Fate Therapeutics.